Silmitasertib sodium salt

SI-6476

Silmitasertib sodium salt, >98% (HPLC)

CAS No. : [1309357-15-0]

Synonyms : CX-4945 sodium salt

IUPAC Name : Sodium 5-((3-chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Silmitasertib sodium salt is a potent, orally bioavailable CK2 inhibitor with low‑nanomolar activity (IC₅₀ = 1 nM for CK2α/α′). It effectively blocks CK2‑dependent signaling processes implicated in tumor growth and cellular proliferation.

References : Siddiqui-Jain A. et al.: Cancer Res., 70(24), 10288-98, 2010; Buontempo F. et al.: Oncotarget., 7(2), 1323-40, 2016; Chon H. J. et al.: Front Pharmacol., 6, 70, 2015.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.